MetaCap

Propanc Biopharma Statistics

NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.78+0.055 (+3.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Propanc Biopharma by the numbers

Propanc Biopharma has a market capitalization of $1.9 million based on 1.05M shares outstanding. With trailing EPS of $-95.92, Propanc Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 52.8% below its 50-day average and 90.4% below its 200-day average.

Average daily trading volume is 188.66K shares, or about $335,813 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PPCB valuation vs. peer median

PPCB compared with the median of 8 peer companies
MetricPPCBPeer medianDifference
Market cap$1.87M$1.89M-1%
Avg. volume188.66K235.18K-20%

Peer median across 8 companies: SBFM, PPBT, XRTX, EOCN, KALA, GNPX, DCOY, REVB.

Valuation

Price and trading

Previous close
1.73
Open
1.79
Day range
1.77 – 2.00
52-week range
1.61 – 315.00
Beta
—
Volume
27.83K

Dividends and events

Additional statistics

Market Cap
1.87M
Eps
-95.92
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
315.00
Week52 Low
1.61
Avg Volume
188.66K
Shares Outstanding
1.05M
Ma50
3.77
Ma200
18.46
Pct From52w High
-99.43%
Pct From52w Low
10.55%

Related